Targeting oncogenic BRAF in human cancer
CA Pratilas, F Xing, DB Solit - Therapeutic Kinase Inhibitors, 2011 - Springer
Abstract Mitogen Activated Protein Kinase (MAPK) pathway activation is a frequent event in
human cancer and is often the result of activating mutations in the BRAF and RAS …
human cancer and is often the result of activating mutations in the BRAF and RAS …
Targeting oncogenic BRAF in human cancer
CA Pratilas, F Xing, DB Solit - Current topics in …, 2012 - pubmed.ncbi.nlm.nih.gov
Mitogen Activated Protein Kinase (MAPK) pathway activation is a frequent event in human
cancer and is often the result of activating mutations in the BRAF and RAS oncogenes …
cancer and is often the result of activating mutations in the BRAF and RAS oncogenes …
Targeting oncogenic BRAF in human cancer.
CA Pratilas, F Xing, DB Solit - Current Topics in Microbiology and …, 2012 - europepmc.org
MAPK pathway activation is a frequent event in human cancer and is often the result of
activating mutations in the BRAF and RAS oncogenes. BRAF missense kinase domain …
activating mutations in the BRAF and RAS oncogenes. BRAF missense kinase domain …
Targeting Oncogenic BRAF in Human Cancer
CA Pratilas, F Xing, DB Solit - … , Albert-Ludwigs-Universität Freiburg, Abt. I …, 2012 - Springer
Abstract Mitogen Activated Protein Kinase (MAPK) pathway activation is a frequent event in
human cancer and is often the result of activating mutations in the BRAF and RAS …
human cancer and is often the result of activating mutations in the BRAF and RAS …
Targeting oncogenic BRAF in human cancer
CA Pratilas, F Xing, DB Solit - Therapeutic Kinase Inhibitors, 2012 - pure.johnshopkins.edu
Abstract Mitogen Activated Protein Kinase (MAPK) pathway activation is a frequent event in
human cancer and is often the result of activating mutations in the BRAF and RAS …
human cancer and is often the result of activating mutations in the BRAF and RAS …
Targeting Oncogenic BRAF in Human Cancer
CA Pratilas, F Xing, DB Solit - Therapeutic Kinase Inhibitors, 2012 - books.google.com
Abstract Mitogen Activated Protein Kinase (MAPK) pathway activation is a frequent event in
human cancer and is often the result of activating mutations in the BRAF and RAS …
human cancer and is often the result of activating mutations in the BRAF and RAS …
[HTML][HTML] TARGETING ONCOGENIC BRAF IN HUMAN CANCER
C Pratilas, F Xing, D Solit - Current topics in microbiology and …, 2012 - ncbi.nlm.nih.gov
MAPK pathway activation is a frequent event in human cancer and is often the result of
activating mutations in the BRAF and RAS oncogenes. BRAF missense kinase domain …
activating mutations in the BRAF and RAS oncogenes. BRAF missense kinase domain …
[引用][C] Targeting Oncogenic BRAF in Human Cancer
CA PRATILAS, F XING… - Current Topics in …, 2012 - pascal-francis.inist.fr
Targeting Oncogenic BRAF in Human Cancer CNRS Inist Pascal-Francis CNRS Pascal and
Francis Bibliographic Databases Simple search Advanced search Search by classification …
Francis Bibliographic Databases Simple search Advanced search Search by classification …